Kiniksa Pharmaceuticals International, plc KNSA Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's change in AR?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported change in AR of $7.63M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's change in AR changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's change in AR increased by 559.9% year-over-year, from -$1.66M to $7.63M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's change in AR?
- Over 2 years (2023 to 2025), Kiniksa Pharmaceuticals International, plc's change in AR has grown at a 74.2% compound annual growth rate (CAGR), from $8.61M to -$26.13M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.